Tinne Gils
Overview
Explore the profile of Tinne Gils including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
79
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jouego C, Decroo T, Netongo P, Gils T
BMJ Glob Health
. 2025 Jan;
10(1).
PMID: 39848636
Introduction: The WHO endorsed the Xpert MTB/RIF (Xpert) technique since 2011 as initial test to diagnose rifampicin-resistant tuberculosis (RR-TB). No systematic review has quantified the proportion of pretreatment attrition in...
2.
Syarif O, Oladele R, Gils T, Rajasingham R, Falconer J, Achii P, et al.
Lancet Glob Health
. 2024 Nov;
13(1):e16-e18.
PMID: 39491054
No abstract available.
3.
Tun N, Oo C, Nwe C, Lynen L, Decroo T, Smithuis F, et al.
J Int AIDS Soc
. 2024 Sep;
27(9):e26355.
PMID: 39267362
No abstract available.
4.
Gils T, Hella J, Jacobs B, Sossen B, Mukoka M, Muyoyeta M, et al.
J Infect Dis
. 2024 Jul;
231(1):e82-e90.
PMID: 39046150
Background: CD4 measurement is pivotal in the management of advanced human immunodeficiency virus (HIV) disease. VISITECT CD4 Advanced Disease (VISITECT; AccuBio, Ltd) is an instrument-free, point-of-care, semiquantitative test allowing visual...
5.
Gils T, Madonsela T, Kamele M, Ayakaka I, van Heerden A, Vlieghe E, et al.
ERJ Open Res
. 2024 Jul;
10(4).
PMID: 39040579
https://bit.ly/3VGHekC.
6.
Lasmi K, Elimian K, Donovan L, Tounaikok N, Traore A, Gils T, et al.
Malar J
. 2024 Jul;
23(1):216.
PMID: 39030554
Background: Recommended since 2012 by the World Health Organization (WHO), seasonal malaria chemoprevention (SMC) is a community-based intervention to prevent malaria in children in African regions where malaria transmission follows...
7.
Pale M, Tivane A, Gils T, Bauhofer A, Nguenha N, Machalele L, et al.
Int Health
. 2024 May;
17(2):159-167.
PMID: 38717389
Background: Evidence on risk factors for respiratory syncytial virus (RSV) in low-resource settings is limited. In Mozambican children <2 y of age with severe acute respiratory infection (SARI), we explored...
8.
Tun N, Smithuis F, Tun N, Hteik M, Ko M, Lynen L, et al.
Int Health
. 2024 Mar;
17(1):23-32.
PMID: 38551313
Background: Pre-exposure prophylaxis (PrEP) is effective for human immunodeficiency virus (HIV) prevention in risk groups. We assessed PrEP uptake and 12-month retention among men who have sex with men (MSM)...
9.
Laxmeshwar C, Das M, Mathur T, Israni T, Jha S, Iyer A, et al.
PLoS One
. 2024 Jan;
19(1):e0298137.
PMID: 38285710
[This corrects the article DOI: 10.1371/journal.pone.0263759.].
10.
Gils T, Kamele M, Madonsela T, Bosman S, Ngubane T, Joseph P, et al.
PLoS One
. 2023 Dec;
18(12):e0296197.
PMID: 38134020
During TB-case finding, we assessed the feasibility of implementing the advanced HIV disease (AHD) care package, including VISITECT CD4 Advanced Disease (VISITECT), a semiquantitative test to identify a CD4≤200cells/μl. Adult...